1. Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors;Perregaux;J. Pharmacol. Exp. Therapeut.,2001
2. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases;Coll;Nat. Med.,2015
3. MCC950 directly targets the NLRP3 ATP-hydolysis motif for inflammasome inhibition;Coll;Nat. Chem. Biol.,2019
4. MCC950 closes the active conformation of NLRP3 to an inactive state;Tapia-Abellan;Nat. Chem. Biol.,2019
5. L. O'Neill, R. Coll, M. Cooper, A. Robertson, K. Schroder, Sulfonylureas and Related Compounds and Use of Same. Patent WO2016/131098 now approved as EP 3,259,253 and US 10,538,487.